Ralliant Corporation $RAL Shares Bought by Hsbc Holdings PLC

Hsbc Holdings PLC boosted its holdings in shares of Ralliant Corporation (NYSE:RAL - Free Report) by 1,585.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 154,825 shares of the company's stock after purchasing an additional 145,637 shares during the quarter. Hsbc Holdings PLC owned approximately 0.14% of Ralliant worth $11,433,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in RAL. Dunhill Financial LLC purchased a new position in shares of Ralliant during the 2nd quarter valued at approximately $25,000. Allworth Financial LP lifted its holdings in Ralliant by 134.4% during the fourth quarter. Allworth Financial LP now owns 511 shares of the company's stock valued at $26,000 after purchasing an additional 293 shares in the last quarter. Palisade Asset Management LLC purchased a new position in Ralliant during the third quarter valued at $26,000. BOKF NA acquired a new stake in shares of Ralliant in the third quarter valued at about $29,000. Finally, Wilmington Savings Fund Society FSB acquired a new stake in shares of Ralliant in the third quarter valued at about $30,000.

Insider Activity at Ralliant

In other Ralliant news, CEO Tamara Newcombe sold 12,936 shares of the firm's stock in a transaction on Friday, August 14th. The stock was sold at an average price of $71.79, for a total transaction of $928,675.44. Following the completion of the sale, the chief executive officer owned 251,967 shares of the company's stock, valued at $18,088,710.93. This trade represents a 4.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen Bick sold 6,062 shares of Ralliant stock in a transaction on Monday, August 17th. The shares were sold at an average price of $72.00, for a total value of $436,464.00. Following the completion of the sale, the senior vice president owned 31,668 shares in the company, valued at $2,280,096. This represents a 16.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.42% of the company's stock.

Ralliant Trading Up 2.5%

Shares of RAL opened at $65.03 on Wednesday. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.75. Ralliant Corporation has a 12-month low of $37.27 and a 12-month high of $75.41. The firm has a 50-day moving average price of $67.17 and a 200 day moving average price of $57.47. The firm has a market capitalization of $7.19 billion, a P/E ratio of -5.99, a P/E/G ratio of 2.36 and a beta of 1.54.

Ralliant (NYSE:RAL - Get Free Report) last issued its earnings results on Thursday, July 30th. The company reported $0.68 EPS for the quarter, topping analysts' consensus estimates of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The company had revenue of $567.80 million for the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Sell-side analysts forecast that Ralliant Corporation will post 2.87 EPS for the current year.

Ralliant Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a $0.05 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant's dividend payout ratio is currently -1.84%.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Morgan Stanley upped their price target on shares of Ralliant from $68.00 to $85.00 and gave the stock an "overweight" rating in a research report on Tuesday, June 23rd. Oppenheimer boosted their price objective on Ralliant from $50.00 to $65.00 and gave the stock an "outperform" rating in a research note on Wednesday, May 13th. TD Cowen increased their target price on Ralliant from $70.00 to $80.00 and gave the company a "buy" rating in a report on Friday, July 31st. Wall Street Zen downgraded Ralliant from a "strong-buy" rating to a "buy" rating in a research report on Sunday, August 30th. Finally, Evercore initiated coverage on Ralliant in a research note on Tuesday, June 9th. They issued an "outperform" rating and a $80.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Ralliant has a consensus rating of "Moderate Buy" and an average target price of $75.70.

Ralliant Profile

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.